StockWatch
·

JENBURKT PHARMACEUTICALS LTD. Q3 FY26 Results

JENBURPHQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue43.025.6%16.6%
Total Income44.845.9%16.5%
Expenditure36.549.7%26.2%
PBT8.3042.1%12.8%
Net Profit5.9341.6%8.9%
OPM17.27%11.49pp1.82pp
NPM13.23%8.11pp3.68pp
EPS13.4441.6%8.9%
View full financials

Informational and educational content only. Not investment advice.